PRZOOM - /newswire/ -
New York, NY, United States, 2008/02/04 - Frost & Sullivan to host briefing titled "Developments in Stent Technologies Open New Cardio Frontiers" - Analyst briefing to be held on February 13.
Industry Analyst, Pramodh Ishwarakrishnan, has completed extensive analysis for the Drug Eluting Stent market. The research expert will lead a short teleconference about new findings that affect the market, followed by a live question and answer session.
You Will Discover: The outcome of the clinical trials within the DES space has opened new vistas for manufacturers of drug eluting stents. The drug eluting stent sector is poised for second entry with newer platforms and prohealing drugs that completely eliminates restenosis and largely addresses the limitations of first generation stents
Highlights of the briefing include: The current and future trends of the stent industry, drivers, challenges and analyst insights.
Who Should Attend: The teleconference is a must for research staff, strategic planners, business development managers, and marketing executives active in the Drug Eluting Stent marketplace or if you are considering entering this dynamic market.
Registration: To pre-register for this event click link below.
Analyst: Pramodh Ishwarakrishnan
Briefing Date: Feb 13 2008
Time: 11am EST/10am CST/4pm GMT/5pm CET & 4:00pm SGT/8:00am GMT
Economic Research & Analytics
Market Research Firm Frost & Sullivan offers economic research & analytics for the countries in which you currently operate or are considering for geographic expansion; includes demographic, socio-metric, economic, political, and regulatory research by industry and region.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Global Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.